Celularity Inc (CELU): Depreciation & Amortization
$7.29M
Year ended 2025-12-31
-8.2%
3-year compound annual growth
-2.2%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.29M | -7.9% | 2026-04-30, From 2025-01-01 |
| 2024-12-31 | $7.92M | -15.0% | 2026-04-30, From 2024-01-01 |
| 2023-12-31 | $9.32M | -1.2% | 2025-05-08, From 2023-01-01 |
| 2022-12-31 | $9.44M | +7.0% | 2024-07-30, From 2022-01-01 |
| 2021-12-31 | $8.82M | +7.9% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $8.17M | n/a | 2022-03-31, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Celularity Inc (CELU) | 2025-12-31 | $7.29M | -7.9% |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | $958.0K | +141.3% |
| Alumis Inc. (ALMS) | 2025-12-31 | $3.50M | +10.9% |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $3.33M | +6.8% |
| NewAmsterdam Pharma Co N.V. (NAMS) | 2025-12-31 | $220.0K | +94.7% |
| CASI Pharmaceuticals, Inc. (CASIF) | 2025-12-31 | $1.20M | -7.7% |
| Scynexis Inc (SCYX) | 2024-12-31 | $0 | -100.0% |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | $1.62M | +29.8% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $284.4K | +427.1% |
Compare CELU, CUE, ALMS, FHTX side by side · Screen every company in Pharmaceutical Preparations ↗